BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

876 related articles for article (PubMed ID: 28095858)

  • 1. miR-4775 promotes colorectal cancer invasion and metastasis via the Smad7/TGFβ-mediated epithelial to mesenchymal transition.
    Zhao S; Sun H; Jiang W; Mi Y; Zhang D; Wen Y; Cheng D; Tang H; Wu S; Yu Y; Liu X; Cui W; Zhang M; Sun X; Zhou Z; Peng Z; Yan D
    Mol Cancer; 2017 Jan; 16(1):12. PubMed ID: 28095858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-182 targets SMAD7 to potentiate TGFβ-induced epithelial-mesenchymal transition and metastasis of cancer cells.
    Yu J; Lei R; Zhuang X; Li X; Li G; Lev S; Segura MF; Zhang X; Hu G
    Nat Commun; 2016 Dec; 7():13884. PubMed ID: 27996004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NR2F2 inhibits Smad7 expression and promotes TGF-β-dependent epithelial-mesenchymal transition of CRC via transactivation of miR-21.
    Wang H; Nie L; Wu L; Liu Q; Guo X
    Biochem Biophys Res Commun; 2017 Mar; 485(1):181-188. PubMed ID: 28192117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-581/SMAD7 Axis Contributes to Colorectal Cancer Metastasis: A Bioinformatic and Experimental Validation-Based Study.
    Zhao X; Liu S; Yan B; Yang J; Chen E
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-367 promotes epithelial-to-mesenchymal transition and invasion of pancreatic ductal adenocarcinoma cells by targeting the Smad7-TGF-β signalling pathway.
    Zhu Z; Xu Y; Zhao J; Liu Q; Feng W; Fan J; Wang P
    Br J Cancer; 2015 Apr; 112(8):1367-75. PubMed ID: 25867271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.
    Meng X; Wu J; Pan C; Wang H; Ying X; Zhou Y; Yu H; Zuo Y; Pan Z; Liu RY; Huang W
    Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-20a triggers metastasis of gallbladder carcinoma.
    Chang Y; Liu C; Yang J; Liu G; Feng F; Tang J; Hu L; Li L; Jiang F; Chen C; Wang R; Yang Y; Jiang X; Wu M; Chen L; Wang H
    J Hepatol; 2013 Sep; 59(3):518-27. PubMed ID: 23665284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-187, a downstream effector of TGFβ pathway, suppresses Smad-mediated epithelial-mesenchymal transition in colorectal cancer.
    Zhang F; Luo Y; Shao Z; Xu L; Liu X; Niu Y; Shi J; Sun X; Liu Y; Ding Y; Zhao L
    Cancer Lett; 2016 Apr; 373(2):203-13. PubMed ID: 26820227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-1269 promotes metastasis and forms a positive feedback loop with TGF-β.
    Bu P; Wang L; Chen KY; Rakhilin N; Sun J; Closa A; Tung KL; King S; Kristine Varanko A; Xu Y; Huan Chen J; Zessin AS; Shealy J; Cummings B; Hsu D; Lipkin SM; Moreno V; Gümüş ZH; Shen X
    Nat Commun; 2015 Apr; 6():6879. PubMed ID: 25872451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-20a-5p promotes colorectal cancer invasion and metastasis by downregulating Smad4.
    Cheng D; Zhao S; Tang H; Zhang D; Sun H; Yu F; Jiang W; Yue B; Wang J; Zhang M; Yu Y; Liu X; Sun X; Zhou Z; Qin X; Zhang X; Yan D; Wen Y; Peng Z
    Oncotarget; 2016 Jul; 7(29):45199-45213. PubMed ID: 27286257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MEGF6 Promotes the Epithelial-to-Mesenchymal Transition via the TGFβ/SMAD Signaling Pathway in Colorectal Cancer Metastasis.
    Hu H; Wang M; Wang H; Liu Z; Guan X; Yang R; Huang R; Tang Q; Zou C; Wang G; Gao X; Wang X
    Cell Physiol Biochem; 2018; 46(5):1895-1906. PubMed ID: 29719292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA TUG1 promoted KIAA1199 expression via miR-600 to accelerate cell metastasis and epithelial-mesenchymal transition in colorectal cancer.
    Sun J; Hu J; Wang G; Yang Z; Zhao C; Zhang X; Wang J
    J Exp Clin Cancer Res; 2018 May; 37(1):106. PubMed ID: 29776371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA CHRF-induced miR-489 loss promotes metastasis of colorectal cancer via TWIST1/EMT signaling pathway.
    Tao Y; Han T; Zhang T; Ma C; Sun C
    Oncotarget; 2017 May; 8(22):36410-36422. PubMed ID: 28430582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-181c Suppresses the Biological Progression of Osteosarcoma via Targeting SMAD7 and Regulating Transforming Growth Factor-β (TGF-β) Signaling Pathway.
    Fu Y; Tang Y; Wang J; Guo Z
    Med Sci Monit; 2019 Jun; 25():4801-4810. PubMed ID: 31251735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-302c represses epithelial-mesenchymal transition and metastasis by targeting transcription factor AP-4 in colorectal cancer.
    Ma W; Liu B; Li J; Jiang J; Zhou R; Huang L; Li X; He X; Zhou Q
    Biomed Pharmacother; 2018 Sep; 105():670-676. PubMed ID: 29906744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-363-3p inhibits the epithelial-to-mesenchymal transition and suppresses metastasis in colorectal cancer by targeting Sox4.
    Hu F; Min J; Cao X; Liu L; Ge Z; Hu J; Li X
    Biochem Biophys Res Commun; 2016 May; 474(1):35-42. PubMed ID: 27084453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-196a-5p promotes metastasis of colorectal cancer via targeting IκBα.
    Xin H; Wang C; Liu Z
    BMC Cancer; 2019 Jan; 19(1):30. PubMed ID: 30621631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer.
    Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z
    J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-296 inhibits the metastasis and epithelial-mesenchymal transition of colorectal cancer by targeting S100A4.
    He Z; Yu L; Luo S; Li M; Li J; Li Q; Sun Y; Wang C
    BMC Cancer; 2017 Feb; 17(1):140. PubMed ID: 28209128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of miR-199b is associated with distant metastasis in colorectal cancer via activation of SIRT1 and inhibition of CREB/KISS1 signaling.
    Shen ZL; Wang B; Jiang KW; Ye CX; Cheng C; Yan YC; Zhang JZ; Yang Y; Gao ZD; Ye YJ; Wang S
    Oncotarget; 2016 Jun; 7(23):35092-105. PubMed ID: 27145368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.